On February 20, 2026, NovaBay Pharmaceuticals, Inc. executed a 1-for-5 reverse stock split, reducing its common stock shares accordingly, but maintaining the same overall ownership percentage for stockholders. This split will be effective on the NYSE American starting February 23, 2026.